tiprankstipranks
Advertisement
Advertisement

SGIOF Stock Latest News

Shionogi to Absorb Torii Pharmaceutical in 2027 to Bolster Specialty Drug Business
Company AnnouncementsShionogi to Absorb Torii Pharmaceutical in 2027 to Bolster Specialty Drug Business
4d ago
Shionogi Lifts Dividend Forecast on Robust HIV and Infectious Disease Growth
PremiumCompany Announcements
Shionogi Lifts Dividend Forecast on Robust HIV and Infectious Disease Growth
4d ago
Shionogi Seals $2.5 Billion RADICAVA Deal to Build Rare Disease Franchise
PremiumCompany Announcements
Shionogi Seals $2.5 Billion RADICAVA Deal to Build Rare Disease Franchise
29d ago
Shionogi boosts ViiV Healthcare stake as Pfizer exits joint HIV venture
PremiumCompany Announcements
Shionogi boosts ViiV Healthcare stake as Pfizer exits joint HIV venture
30d ago
Shionogi Secures ¥300 Billion Bridge Loan for Expanded ViiV Healthcare Stake
PremiumCompany Announcements
Shionogi Secures ¥300 Billion Bridge Loan for Expanded ViiV Healthcare Stake
1M ago
Shionogi Takes Full Control of Sleep Disorder JV in USD 100 Million Deal
PremiumCompany AnnouncementsShionogi Takes Full Control of Sleep Disorder JV in USD 100 Million Deal
1M ago
Shionogi Secures ¥360 Billion Bridge Loan to Fund Global RADICAVA Rights Deal
Premium
Company Announcements
Shionogi Secures ¥360 Billion Bridge Loan to Fund Global RADICAVA Rights Deal
1M ago
Shionogi Wins Japan Nod for XOCOVA as First Oral Post‑Exposure COVID‑19 Prophylactic
Premium
Company Announcements
Shionogi Wins Japan Nod for XOCOVA as First Oral Post‑Exposure COVID‑19 Prophylactic
1M ago
Shionogi Advances S-531011 Cancer Trial, Keeping Long-Term Upside in Play for SGIOF Investors
PremiumCompany Announcements
Shionogi Advances S-531011 Cancer Trial, Keeping Long-Term Upside in Play for SGIOF Investors
1M ago
SGIOF
Shionogi Seeks Japan Approval for New CORECTIM Lotion for Atopic Dermatitis
PremiumCompany Announcements
Shionogi Seeks Japan Approval for New CORECTIM Lotion for Atopic Dermatitis
2M ago
Shionogi’s S-606001 Pompe Trial: A Small Rare-Disease Bet With Big Upside Potential
PremiumCompany Announcements
Shionogi’s S-606001 Pompe Trial: A Small Rare-Disease Bet With Big Upside Potential
2M ago
SGIOF
Shionogi to Absorb Torii Pharmaceutical in 2027 to Boost Domestic Pharma Synergies
PremiumCompany Announcements
Shionogi to Absorb Torii Pharmaceutical in 2027 to Boost Domestic Pharma Synergies
2M ago
Shionogi’s Oral RSV Antiviral Moves Forward: What Investors Should Watch in This Phase 2b Trial
PremiumCompany AnnouncementsShionogi’s Oral RSV Antiviral Moves Forward: What Investors Should Watch in This Phase 2b Trial
3M ago
SGIOF
Shionogi Delivers Double-Digit Profit Growth and Confirms FY2026 Outlook
Premium
Company Announcements
Shionogi Delivers Double-Digit Profit Growth and Confirms FY2026 Outlook
3M ago
Shionogi Lifts Revenue and Profit on Royalty Growth and Overseas Expansion
Premium
Company Announcements
Shionogi Lifts Revenue and Profit on Royalty Growth and Overseas Expansion
3M ago
SGIOF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
SGIOF Earnings this Week: How Will it Perform?
3M ago
Shionogi Boosts Stake in ViiV Healthcare as Pfizer Exits Joint HIV Venture
PremiumCompany Announcements
Shionogi Boosts Stake in ViiV Healthcare as Pfizer Exits Joint HIV Venture
3M ago
Shionogi Buys Global RADICAVA Rights in $2.5 Billion ALS Drug Deal to Build Rare Disease Platform
PremiumCompany Announcements
Shionogi Buys Global RADICAVA Rights in $2.5 Billion ALS Drug Deal to Build Rare Disease Platform
4M ago
Shionogi Wins Japan Approval for Rapid-Acting Depression Drug ZURZUVAE
PremiumCompany Announcements
Shionogi Wins Japan Approval for Rapid-Acting Depression Drug ZURZUVAE
4M ago
Shionogi Completes Acquisition of Japan Tobacco’s Pharmaceutical Business
PremiumCompany AnnouncementsShionogi Completes Acquisition of Japan Tobacco’s Pharmaceutical Business
5M ago
Shionogi Announces Corrections to Q2 2025 Financial Results
Premium
Company Announcements
Shionogi Announces Corrections to Q2 2025 Financial Results
5M ago
Shionogi & Co. Reports Steady Q2 Earnings Amid Strategic Expansion
Premium
Company Announcements
Shionogi & Co. Reports Steady Q2 Earnings Amid Strategic Expansion
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >